Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Qu Qi, Lijuan Cao, Feiyan Li, Hong Wang, Huiying Liu, Haiping Hao & Kun Hao. (2015) Salvianolic acid B as a substrate and weak catechol-O-methyltransferase inhibitor in rats. Xenobiotica 45:9, pages 820-827.
Read now
Read now
Cornelis J Van der Schyf. (2015) Rational drug discovery design approaches for treating Parkinson’s disease. Expert Opinion on Drug Discovery 10:7, pages 713-741.
Read now
Read now
Articles from other publishers (43)
Hacer Bayrak, Asmaa M. Fahim, Fatma Yaylaci Karahalil, Imane Azafad, Gülsüm Merve Boyraci & Ebru Taflan. (2023) Synthesis, antioxidant activity, docking simulation, and computational investigation of novel heterocyclic compounds and Schiff bases from picric acid. Journal of Molecular Structure 1281, pages 135184.
Crossref
Crossref
Cindy Bandala, Noemi Cárdenas-Rodríguez, Julieta Griselda Mendoza-Torreblanca, Itzel Jatziri Contreras-García, Valentín Martínez-López, Teresita Rocio Cruz-Hernández, Jazmín Carro-Rodríguez, Marco Antonio Vargas-Hernández, Iván Ignacio-Mejía, Alfonso Alfaro-Rodriguez & Eleazar Lara-Padilla. (2023) Therapeutic Potential of Dopamine and Related Drugs as Anti-Inflammatories and Antioxidants in Neuronal and Non-Neuronal Pathologies. Pharmaceutics 15:2, pages 693.
Crossref
Crossref
Arjun Bodkhe, Vilas Sudrik, Dnyaneshwar Karpe & Shamrao Lawande. (2022) Development of A Novel One-pot Process for the Synthesis of Tolcapone. Oriental Journal Of Chemistry 38:6, pages 1561-1566.
Crossref
Crossref
Junshu Yang, Christopher Brown, Wayland Noland, Timothy J. Johnson & Yinduo Ji. (2022) Identification and Validation of a Novel Antibacterial Compound MZ-01 against Methicillin-Resistant Staphylococcus aureus. Antibiotics 11:11, pages 1550.
Crossref
Crossref
J. Koschel, K. Ray Chaudhuri, L. Tönges, M. Thiel, V. Raeder & W. H. Jost. (2021) Implications of dopaminergic medication withdrawal in Parkinson’s disease. Journal of Neural Transmission 129:9, pages 1169-1178.
Crossref
Crossref
Yaquelyn Casanova, Sofía Negro, Karla Slowing, Luis García-García, Ana Fernández-Carballido, Mahdieh Rahmani & Emilia Barcia. (2022) Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease. Pharmaceutics 14:5, pages 1080.
Crossref
Crossref
Lale Carstensen, Stephan Beil, Hilmar Börnick & Stefan Stolte. (2022) Structure-related endocrine-disrupting potential of environmental transformation products of benzophenone-type UV filters: A review. Journal of Hazardous Materials 430, pages 128495.
Crossref
Crossref
Margherita Fabbri, Joaquim J. Ferreira & Olivier Rascol. (2022) COMT Inhibitors in the Management of Parkinson’s Disease. CNS Drugs 36:3, pages 261-282.
Crossref
Crossref
Dag Nyholm & Wolfgang H. Jost. (2022) Levodopa–entacapone–carbidopa intestinal gel infusion in advanced Parkinson’s disease: real-world experience and practical guidance. Therapeutic Advances in Neurological Disorders 15, pages 175628642211080.
Crossref
Crossref
Trang N. N. Vo, Karen Frei & Daniel D. Truong. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
2993
3013
.
Miguel Reina, Eduardo Gabriel Guzmán-López, Isabella Romeo, Tiziana Marino, Nino Russo & Annia Galano. (2021)
Computationally designed
p
-coumaric acid analogs: searching for neuroprotective antioxidants
. New Journal of Chemistry 45:32, pages 14369-14380.
Crossref
Crossref
Antony Danish Isravel, Jebasingh Kores Jeyaraj, Sasitha Thangasamy & Winfred Jebaraj John. (2021) DFT, NBO, HOMO-LUMO, NCI, stability, Fukui function and hole – Electron analyses of tolcapone. Computational and Theoretical Chemistry 1202, pages 113296.
Crossref
Crossref
Inci Söğütlü, Evan Abdulkarim Mahmood, Saeid Ahmadizadeh Shendy, Saeideh Ebrahimiasl & Esmail Vessally. (2021) Recent progress in application of nanocatalysts for carbonylative Suzuki cross-coupling reactions. RSC Advances 11:4, pages 2112-2125.
Crossref
Crossref
S. Greten, J. I. Müller-Funogea, F. Wegner, G. U. Höglinger, N. Simon, U. Junius-Walker, S. Gerbel, O. Krause & M. Klietz. (2020) Drug safety profiles in geriatric patients with Parkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis. Journal of Neural Transmission 128:1, pages 49-60.
Crossref
Crossref
Nelin Hacıoğlu, Tuğba Güngör, Esra Tokay, Ferah Cömert Önder, Mehmet Ay & Feray Köçkar. (2020) Synthesis and biological evaluation of 2,4,6-trinitroaniline derivatives as potent antitumor agents. Monatshefte für Chemie - Chemical Monthly 151:10, pages 1629-1641.
Crossref
Crossref
Jonah A. Moore, Michaela Meakin, Mikaela H. Earl, Tiffany M. Kummer, Jeremy P. McAleer & Timothy E. Long. (2020) Effects of caspofungin, tolcapone and other FDA-approved medications on MRSA susceptibility to vancomycin. Journal of Global Antimicrobial Resistance 22, pages 283-289.
Crossref
Crossref
Bianca L.B. Marino, Lucilene R. de Souza, Kessia P.A. Sousa, Jaderson V. Ferreira, Elias C. Padilha, Carlos H.T.P. da Silva, Carlton A. Taft & Lorane I.S. Hage-Melim. (2020) Parkinson’s Disease: A Review from Pathophysiology to Treatment. Mini-Reviews in Medicinal Chemistry 20:9, pages 754-767.
Crossref
Crossref
Miguel Rodríguez, Joyce Gutiérrez, José Domínguez, Philippe A. Peixoto, Alexis Fernández, Noris Rodríguez, Denis Deffieux, Luis Rojas, Stéphane Quideau, Laurent Pouységu & Jaime Charris. (2020) Synthesis and leishmanicidal evaluation of sulfanyl‐ and sulfonyl‐tethered functionalized benzoate derivatives featuring a nitroimidazole moiety. Archiv der Pharmazie 353:5.
Crossref
Crossref
Trang N. N. Vo, Karen Frei & Daniel D. Truong. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
21
.
Theresa A. Zesiewicz. (2019) Parkinson Disease. CONTINUUM: Lifelong Learning in Neurology 25:4, pages 896-918.
Crossref
Crossref
Xin Wang, Murat Cirit, John S. Wishnok, Linda G. Griffith & Steven R. Tannenbaum. (2019) Analysis of an Integrated Human Multiorgan Microphysiological System for Combined Tolcapone Metabolism and Brain Metabolomics. Analytical Chemistry 91:13, pages 8667-8675.
Crossref
Crossref
Tamires Cunha Almeida, Luis Henrique Gonzaga Ribeiro, Luiza Braga Ferreira dos Santos, Cleiton Moreira da Silva, Renata Tupinambá Branquinho, Marta de Lana, Fernanda Ramos Gadelha & Ângelo de Fátima. (2018) Synthesis, in vitro and in vivo anti-Trypanosoma cruzi and toxicological activities of nitroaromatic Schiff bases. Biomedicine & Pharmacotherapy 108, pages 1703-1711.
Crossref
Crossref
Irene Katsaiti & John Nixon. (2018) Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson’s Disease Patients? A Systematic Review. Journal of Parkinson's Disease 8:2, pages 217-231.
Crossref
Crossref
Dorota Olender, Justyna Żwawiak & Lucjusz Zaprutko. (2018) Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines. Pharmaceuticals 11:2, pages 54.
Crossref
Crossref
Manuela Crisan, Gabriela Vlase, Elisabeta I. Szerb & Titus Vlase. (2018) Thermal and kinetics studies of primary, secondary and tertiary alkanolammonium salts of 4-nitrobenzoic acid. Journal of Thermal Analysis and Calorimetry 132:2, pages 1409-1418.
Crossref
Crossref
Manuela Crisan, Liliana Halip, Paulina Bourosh, Sergiu Adrian Chicu & Yurii Chumakov. (2017) Synthesis, structure and toxicity evaluation of ethanolamine nitro/chloronitrobenzoates: a combined experimental and theoretical study. Chemistry Central Journal 11:1.
Crossref
Crossref
Bracken F. Roberts, Yongsheng Zheng, Jacob Cleaveleand, Sukjun Lee, Eunyoung Lee, Lawrence Ayong, Yu Yuan & Debopam Chakrabarti. (2017) 4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle. International Journal for Parasitology: Drugs and Drug Resistance 7:1, pages 120-129.
Crossref
Crossref
Yong Li, Xilei Xie, Xiu’e Yang, Mengmeng Li, Xiaoyun Jiao, Yuhui Sun, Xu Wang & Bo Tang. (2017) Two-photon fluorescent probe for revealing drug-induced hepatotoxicity via mapping fluctuation of peroxynitrite. Chemical Science 8:5, pages 4006-4011.
Crossref
Crossref
Julie Eakins, Caroline Bauch, Heather Woodhouse, Benjamin Park, Samantha Bevan, Clive Dilworth & Paul Walker. (2016) A combined in vitro approach to improve the prediction of mitochondrial toxicants. Toxicology in Vitro 34, pages 161-170.
Crossref
Crossref
Xia Lv, Xin-Xin Wang, Jie Hou, Zhong-Ze Fang, Jing-Jing Wu, Yun-Feng Cao, Shu-Wen Liu, Guang-Bo Ge & Ling Yang. (2016) Comparison of the inhibitory effects of tolcapone and entacapone against human UDP-glucuronosyltransferases. Toxicology and Applied Pharmacology 301, pages 42-49.
Crossref
Crossref
Fabian Schumacher, Sudipta Chakraborty, Burkhard Kleuser, Erich Gulbins, Tanja Schwerdtle, Michael Aschner & Julia Bornhorst. (2015) Highly sensitive isotope-dilution liquid-chromatography–electrospray ionization–tandem-mass spectrometry approach to study the drug-mediated modulation of dopamine and serotonin levels in Caenorhabditis elegans. Talanta 144, pages 71-79.
Crossref
Crossref
Oleg V. Ershov, Veronika N. Maksimova, Konstanin V. Lipin, Mikhail Yu. Belikov, Mikhail Yu. Ievlev, Victor A. Tafeenko & Oleg E. Nasakin. (2015) Regiospecific synthesis of gem -dinitro derivatives of 2-halogenocycloalka[ b ]pyridine-3,4-dicarbonitriles. Tetrahedron 71:39, pages 7445-7450.
Crossref
Crossref
Stephen Patterson & Susan Wyllie. (2014) Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects. Trends in Parasitology 30:6, pages 289-298.
Crossref
Crossref
Thomas Müller. (2013) Tolcapone addition improves Parkinson’s disease associated nonmotor symptoms. Therapeutic Advances in Neurological Disorders 7:2, pages 77-82.
Crossref
Crossref
Hao Ye, Qi Liu & Jia Wei. (2014) Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning. PLoS ONE 9:2, pages e87864.
Crossref
Crossref
Howard S. Smith & Andras Laufer. (2014) Opioid induced nausea and vomiting. European Journal of Pharmacology 722, pages 67-78.
Crossref
Crossref
Arif Dalvi, Kelly E. Lyons & Rajesh Pahwa. 2014. Inflammation in Parkinson's Disease. Inflammation in Parkinson's Disease
1
24
.
Ronald F. Pfeiffer. 2013. Handbook of Parkinson’s Disease. Handbook of Parkinson’s Disease
448
465
.
R Branford, J Droney & JR Ross. (2012) Opioid genetics: the key to personalized pain control?. Clinical Genetics 82:4, pages 301-310.
Crossref
Crossref
Manuel Ellermann, Christian Lerner, Guillaume Burgy, Andreas Ehler, Caterina Bissantz, Roland Jakob-Roetne, Ralph Paulini, Oliver Allemann, Heloïse Tissot, Dan Grünstein, Martine Stihle, Francois Diederich & Markus G. Rudolph. (2012)
Catechol-
O
-methyltransferase in complex with substituted 3′-deoxyribose bisubstrate inhibitors
. Acta Crystallographica Section D Biological Crystallography 68:3, pages 253-260.
Crossref
Crossref
Shivakumar Chitturi & Geoffrey C. Farrell. 2011. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver
703
783
.
Saviana Di Giovanni, Simona Eleuteri, Katerina E. Paleologou, Guowei Yin, Markus Zweckstetter, Pierre-Alain Carrupt & Hilal A. Lashuel. (2010) Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity. Journal of Biological Chemistry 285:20, pages 14941-14954.
Crossref
Crossref
Abha Harfouche, Wael Alata, Karine Leblanc, Bruno Figadère & Alexandre Maciuk. (2021) Label-Free LC/HRMS-Based Enzymatic Activity Assay for the Detection of DDC, MAO and COMT Inhibitors in Natural Extracts. SSRN Electronic Journal.
Crossref
Crossref